_2020091018165303jzv.jpg "Decoding The World Of ETF")
- Moneycontrol /
- Market /
- Pharmaceuticals /
- QUARTERLY RESULTS
BSE Live
Sep 18, 16:00Prev. Close
374.80
Open Price
381.35
Bid Price (Qty.)
404.25 (99)
Offer Price (Qty.)
404.25 (1)
NSE Live
Sep 18, 15:59Prev. Close
374.65
Open Price
378.00
Bid Price (Qty.)
405.15 (67)
Offer Price (Qty.)
0.00 (0)
| Quarterly Results of RPG Life Sciences (in Rs. Cr.) | Jun '20 | Mar '20 | Dec '19 | Sep '19 | Jun '19 | |
| Net Sales/Income from operations | 91.65 | 88.67 | 94.37 | 98.49 | 94.04 | |
| Other Operating Income | -- | -- | -- | -- | -- | |
| Total Income From Operations | 91.65 | 88.67 | 94.37 | 98.49 | 94.04 | |
| EXPENDITURE | ||||||
| Consumption of Raw Materials | 19.14 | 18.17 | 22.73 | 17.46 | 16.77 | |
| Purchase of Traded Goods | 15.05 | 9.27 | 18.49 | 19.51 | 11.34 | |
| Increase/Decrease in Stocks | -4.92 | 3.08 | -9.32 | -4.36 | 4.62 | |
| Power & Fuel | -- | -- | -- | -- | -- | |
| Employees Cost | 24.00 | 23.68 | 24.17 | 24.93 | 23.12 | |
| depreciat | 4.16 | 4.12 | 4.16 | 4.16 | 3.92 | |
| Excise Duty | -- | -- | -- | -- | -- | |
| Admin. And Selling Expenses | -- | -- | -- | -- | -- | |
| R & D Expenses | -- | -- | -- | -- | -- | |
| Provisions And Contingencies | -- | -- | -- | -- | -- | |
| Exp. Capitalised | -- | -- | -- | -- | -- | |
| Other Expenses | 21.53 | 21.97 | 23.41 | 24.54 | 22.84 | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 12.69 | 8.38 | 10.73 | 12.25 | 11.43 | |
| Other Income | 0.45 | 0.38 | 0.04 | 0.15 | 0.16 | |
| P/L Before Int., Excpt. Items & Tax | 13.14 | 8.76 | 10.77 | 12.40 | 11.59 | |
| Interest | 0.31 | 0.30 | 0.36 | 0.36 | 0.73 | |
| P/L Before Exceptional Items & Tax | 12.83 | 8.46 | 10.41 | 12.04 | 10.86 | |
| Exceptional Items | -- | -5.32 | -- | -- | -- | |
| P/L Before Tax | 12.83 | 3.14 | 10.41 | 12.04 | 10.86 | |
| Tax | 3.77 | 0.16 | 2.50 | 2.27 | 2.51 | |
| P/L After Tax from Ordinary Activities | 9.06 | 2.98 | 7.91 | 9.77 | 8.35 | |
| Prior Year Adjustments | -- | -- | -- | -- | -- | |
| Extra Ordinary Items | -- | -- | -- | -- | -- | |
| Net Profit/(Loss) For the Period | 9.06 | 2.98 | 7.91 | 9.77 | 8.35 | |
| Equity Share Capital | 13.23 | 13.23 | 13.23 | 13.23 | 13.23 | |
| Reserves Excluding Revaluation Reserves | -- | -- | -- | -- | -- | |
| Equity Dividend Rate (%) | -- | -- | -- | -- | -- | |
| EPS Before Extra Ordinary | ||||||
| Basic EPS | 5.48 | 1.80 | 4.78 | 5.91 | 5.05 | |
| Diluted EPS | 5.48 | 1.80 | 4.78 | 5.91 | 5.05 | |
| EPS After Extra Ordinary | ||||||
| Basic EPS. | 5.48 | 1.80 | 4.78 | 5.91 | 5.05 | |
| Diluted EPS. | 5.48 | 1.80 | 4.78 | 5.91 | 5.05 | |
| Public Share Holding | ||||||
| No Of Shares (Crores) | -- | -- | -- | -- | -- | |
| Share Holding (%) | -- | -- | -- | -- | -- | |
| Promoters and Promoter Group Shareholding | ||||||
| a) Pledged/Encumbered | ||||||
| - Number of shares (Crores) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | -- | -- | |
| b) Non-encumbered | ||||||
| - Number of shares (Crores). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total sh. of prom. and promoter group). | -- | -- | -- | -- | -- | |
| - Per. of shares (as a % of the total Share Cap. of the company). | -- | -- | -- | -- | -- |
03.08.2020
RPG Life Standalone June 2020 Net Sales at Rs 91.65 crore, down 2.54% Y-o-Y
30.12.2019
Breakout buys: SBI, Hindalco among 10 stocks to consider for January series
30.07.2019
RPG Life Sciences profit jumps four-fold led by domestic formulation biz growth
30.07.2019
RPG Life Standalone June 2019 Net Sales at Rs 94.04 crore, up 17.71% Y-o-Y
03.08.2020
RPG Life Standalone June 2020 Net Sales at Rs 91.65 crore, down 2.54% Y-o-Y
30.07.2019
RPG Life Standalone June 2019 Net Sales at Rs 94.04 crore, up 17.71% Y-o-Y
30.04.2019
RPG Life Standalone March 2019 Net Sales at Rs 68.80 crore, down 17.57% Y-o-Y
06.02.2019
RPG Life Standalone December 2018 Net Sales at Rs 90.97 crore, down 4.9% Y-o-Y
